Stocks and Investing Stocks and Investing
Wed, January 12, 2022
[ 12:00 AM ] - United States, WOPRAI
Brent Bracelin Maintained (SPT) at Buy with Decreased Target to $125 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Trevor Williams Maintained (SQ) at Strong Buy with Decreased Target to $200 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Brent Bracelin Maintained (SQSP) at Buy with Decreased Target to $45 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Sunil Rajgopal Initiated (SQSP) at Strong Buy and Held Target at $42 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Gabe Hajde Maintained (SON) at Hold with Decreased Target to $58 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Adam Tindle Maintained (SNX) at Strong Buy with Increased Target to $170 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Shannon Cross Upgraded (SNX) to Strong Buy and Held Target at $124 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Jim Suva Maintained (SNX) at Strong Buy with Increased Target to $165 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Raimo Lenschow Upgraded (SNOW) to Buy on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Eric Luebchow Downgraded (CCOI) to Sell and Decreased Target to $65 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Blayne Curtis Maintained (CRUS) at Buy with Increased Target to $120 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Eric Beder Maintained (BBW) at Strong Buy with Increased Target to $33 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Gabe Hajde Maintained (BERY) at Buy with Increased Target to $86 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Brent Bracelin Maintained (BIGC) at Buy with Decreased Target to $70 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Raimo Lenschow Maintained (BIGC) at Hold with Decreased Target to $36 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Christopher Raymond Downgraded (BIIB) to Hold and Decreased Target to $216 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Ami Fadia Maintained (BIIB) at Strong Buy with Decreased Target to $292 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Salim Syed Maintained (BIIB) at Hold with Decreased Target to $207 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Laura Chico Maintained (BIIB) at Hold with Decreased Target to $195 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
John Ransom Maintained (ALHC) at Buy with Decreased Target to $20 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
William Katz Maintained (AB) at Strong Buy with Increased Target to $65 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Gary Nachman Maintained (ABBV) at Buy with Increased Target to $153 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Karen Short Maintained (ACI) at Hold with Increased Target to $32 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Simeon Gutman Maintained (ACI) at Sell with Increased Target to $26 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Brian Meredith Maintained (ACGL) at Strong Buy with Increased Target to $52 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Raimo Lenschow Maintained (APPN) at Sell with Decreased Target to $47 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Leo Mariani Maintained (APA) at Buy with Increased Target to $37 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
David Buckley Maintained (AEO) at Hold with Decreased Target to $28 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Blayne Curtis Maintained (ADI) at Buy with Decreased Target to $180 on, Jan 12th, 2022
[ 12:00 AM ] - United States, WOPRAI
Andrew Berens Maintained (BPMC) at Buy with Decreased Target to $120 on, Jan 12th, 2022

Andrew Berens Maintained (BPMC) at Buy with Decreased Target to $120 on, Jan 12th, 2022


Published on 2024-10-27 19:14:36 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of SVB Leerink, Maintained "Blueprint Medicines Corporation" (BPMC) at Buy with Decreased Target from $132 to $120 on, Jan 12th, 2022.

Andrew has made no other calls on BPMC in the last 4 months.



There are 3 other peers that have a rating on BPMC. Out of the 3 peers that are also analyzing BPMC, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • David Lebovitz of "Morgan Stanley" Maintained at Hold with Increased Target to $111 on, Friday, October 29th, 2021


These are the ratings of the 2 analyists that currently disagree with Andrew

  • Michael Schmitz of "Guggenheim" Maintained at Strong Buy with Increased Target to $122 on, Monday, January 3rd, 2022
  • Dane Leone of "Raymond James" Maintained at Strong Buy with Increased Target to $133 on, Wednesday, November 10th, 2021

Contributing Sources